RecruitingNot applicableNCT06625372
Comparison of Intralipid With SMOF Lipid Following HSCT
Studying Complications after hematopoietic stem cell transplantation
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Shahid Beheshti University
- Principal Investigator
- Zahra Vahdat Shariatpanahi, ProfessorSchool of Nutrition Sciences and Food Technology, Shahid Beheshti University of Medical Sciences
- Intervention
- SMOF lipid(dietary_supplement)
- Enrollment
- 50 enrolled
- Eligibility
- 2-18 years · All sexes
- Timeline
- 2024 – 2025
Study locations (1)
- Children's Medical Center, Pediatrics Center of Excellence, Tehran University of Medical Sciences, Tehran, Iran, Tehran, Iran
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06625372 on ClinicalTrials.govOther trials for Complications after hematopoietic stem cell transplantation
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06241274Moxibustion in the Treatment of Hemorrhagic Cystitis After Allo-HSCTUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology
- RECRUITINGNANCT06198517Moxibustion for the Prevention of Hemorrhagic Cystitis After Allo-HSCTYi Zhang
See all trials for Complications after hematopoietic stem cell transplantation →